+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Vascular Anomalies- Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Anomalies- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Von Hippel-Lindau Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Von Hippel-Lindau Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Post-transplant Lymphoproliferative Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adrenal Crisis - Pipeline Insight, 2025 - Product Thumbnail Image

Adrenal Crisis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Craniopharyngioma - Pipeline Insight, 2025 - Product Thumbnail Image

Craniopharyngioma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

50S Ribosomal Subunit (50S RNA) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
5-HT1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT1 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
5-HT2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT2 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
5-HT4 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT4 Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
5-HT4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

5-HT4 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
CDK12 Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

CDK12 Inhibitor- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Cholangiocarcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Cholangiocarcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
Chronic Myelomonocytic Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Myelomonocytic Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Relapsed/refractory Acute Myeloid Leukemia (AML)- Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed/refractory Acute Myeloid Leukemia (AML)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sanfilippo Syndrome Type A (MPS IIIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Sanfilippo Syndrome Type A (MPS IIIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Schizophrenia- Pipeline Insight, 2025 - Product Thumbnail Image

Schizophrenia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Loading Indicator